BrightSpring Health Services Inc. (BTSG) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
BrightSpring Health Services Inc. (BTSG) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How BTSG Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $12.91B | 11.8% | 2.3% | $189.1M | $394.7M | 5.5% |
| FY 2024 | $10.07B | 12.6% | 1.1% | $20.5M | -$57.1M | 2.1% |
| FY 2023 | $7.69B | 44% | 0.8% | -$154.6M | -$135.3M | 0.8% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BTSG)
- ✓Live walkthrough of BTSG's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
BTSG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +28.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BTSG today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BTSG. Explore sector supply chains on /butterfly.
BTSG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is BrightSpring Health Services Inc. (BTSG)?
In FY 2025 (10-K), BTSG converted $12.9B of revenue into a 11.8% gross margin, 2.3% operating margin, and $394.7M in free cash flow (3.1% FCF margin).